Wells joins UCSF as first Hind Professor

James Wells, PhD, a leader in the development of new technologies to aid drug discovery and protein engineering, joins UCSF as the first holder of the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences. Wells will hold joint faculty appointments in the Schools of Pharmacy and Medicine. Wells is a member of the National Academy of Sciences and co-founder of Sunesis, the South San Francisco pharmaceutical company. “Jim is a highly regarded and highly accomplished scientist,” said Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy. “We count ourselves lucky he chose UCSF as his next research home. He is the perfect first holder of the Hind professorship.”

More info

Pioneer in Biotech Research and Drug Development Appointed to UCSF Faculty and Hinds Establish Pharmacy's First Distinguished Professorship.


School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, Dean's Office

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.